2022
DOI: 10.12998/wjcc.v10.i6.1754
|View full text |Cite
|
Sign up to set email alerts
|

Gut-brain axis: Focus on gut metabolites short-chain fatty acids

Abstract: Emerging evidence supports that the gut microbiome, reconsidered as a new organ in the human body, can not only affect the local gut, but also communicate with the brain via multiple pathways related to neuroendocrine, immune, and neural pathways, thereby proposing the new concept of the microbiome-gut-brain (MGB) axis. Recently, the role of short-chain fatty acids (SCFAs), which are the main anaerobic fermented metabolites of the gut microbiota in the MGB axis, has garnered significant … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
23
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
6
2
1

Relationship

0
9

Authors

Journals

citations
Cited by 33 publications
(23 citation statements)
references
References 71 publications
(74 reference statements)
0
23
0
Order By: Relevance
“…Furthermore, B. bifidum , L. acidophilus , L. casei , and L. rhamnosus exerted a significant effect on modulating anxiety and inflammatory processes in CFS patients [ 232 ]. However, it is difficult to determine which probiotic strain was more effective in attenuating depression symptoms because multiple strains are mostly used in clinical trials [ 80 ], and there are no studies with a placebo-controlled group evaluating the effectiveness of one probiotic strain versus another single strain in depressive disorders. However, it is possible to determine the properties of psychobiotics that they should possess, as shown in Figure 1 .…”
Section: Probiotic Preparations In Depressionmentioning
confidence: 99%
See 1 more Smart Citation
“…Furthermore, B. bifidum , L. acidophilus , L. casei , and L. rhamnosus exerted a significant effect on modulating anxiety and inflammatory processes in CFS patients [ 232 ]. However, it is difficult to determine which probiotic strain was more effective in attenuating depression symptoms because multiple strains are mostly used in clinical trials [ 80 ], and there are no studies with a placebo-controlled group evaluating the effectiveness of one probiotic strain versus another single strain in depressive disorders. However, it is possible to determine the properties of psychobiotics that they should possess, as shown in Figure 1 .…”
Section: Probiotic Preparations In Depressionmentioning
confidence: 99%
“…The probiotics supplemented to healthy people did not exert an effect. Moreover, in an umbrella meta-analysis ( n = 10) with 8886 participants reported by Musazadeh and co-workers [ 80 ], it was demonstrated that probiotics administered in an appropriate dose for a sufficiently long time had a significant effect on reducing depression. The specific probiotics should be administered at a dose of >10 10 CFU per day for >8 weeks to alleviate the symptoms of depression.…”
Section: Probiotic Preparations In Depressionmentioning
confidence: 99%
“…One of the SCFAs, butyrate, was proposed as an agent with an indirect effect on regulating inflammatory visceral pain. Its injection in rat and mouse brains stimulated the production of brain-derived neurotrophic factor (BDNF), which favors neurogenesis, memory formation, and mood stabilization [ 112 , 113 , 114 ].…”
Section: Visceral Pain Peripheral Mechanisms Of Pain Regulation and Ibsmentioning
confidence: 99%
“…There are two key GPCRs mediating such activity—free fatty acid receptor 2 (FFAR2) and FFAR3 [ 36 ]. However, they also act as epigenetic modulators, inhibiting histone deacetylase (HDAC) [ 37 ], and this may be more important in terms of brain activity than the action through GPCRs [ 38 ]. It has been speculated that they reach the brain via the bloodstream, but this has yet to be definitively shown using nonpharmacological doses.…”
Section: How Do Gut Microbes Communicate With the Brain?mentioning
confidence: 99%